查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1718095

无细胞 DNA 分离与萃取市场：2025 年至 2030 年全球预测（按产品类型、无细胞 DNA 类型、样本类型、研究领域、应用和最终用户）

Cell-Free DNA Isolation & Extraction Market by Product Type, Cell-Free DNA Type, Sample Type, Research Area, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

无细胞 DNA 分离和萃取市场预计在 2024 年价值 10.9 亿美元，在 2025 年达到 12.3 亿美元，并以 13.45% 的复合年增长率增长，到 2030 年达到 23.2 亿美元。

主要市场统计数据
基准年2024年 10.9亿美元
预计2025年 12.3亿美元
预测年份 2030 23.2亿美元
复合年增长率（%） 13.45%

近年来，无细胞DNA分离和萃取领域已成为分子诊断和个人化医疗进步的重要贡献者。快速的技术发展加上对基因生物标记的深入了解极大地重新定义了研究和临床应用的能力。随着对高品质、可重复结果的需求不断增加，实验室和研究机构越来越多地投资于创新方法，以简化提取过程，同时保持珍贵生物样本的完整性。

科学界和决策者越来越认识到准确、高效的无细胞 DNA 萃取技术的重要性。这种演变的突出表现是从传统方法转向强调自动化、敏感性和扩充性的更复杂方法的转变。增强的分离技术不仅可以加速基因异常的检测，而且还有助于早期诊断、个人化治疗计划和有效监测疾病进展。

随着主要生物医学和诊断公司之间的竞争日益激烈，开发适用于各种研究和临床环境的稳健且适应性强的标准化通讯协定也成为当务之急。技术整合、监管指导和不断变化的市场动态的新兴趋势正在极大地改变市场格局，带来新的机会和挑战，需要专家审查和策略规划。

无细胞DNA技术领域的变革

在重大技术和科学创新的推动下，无细胞 DNA 分离和萃取领域正在发生变革性转变。新的自动化平台正在重新定义营运效率，确保提取过程的可重复性和可靠性，同时减少人工干预。先进的设备和改进的化学试剂为更高的产量和纯度水平铺平了道路，这对于基因组序列测定、液态生物检体和非侵入性产前检测等下游应用至关重要。

不断变化的法规和不断发展的品质标准为行业相关人员带来了挑战和机会。现在，研究人员和行业领导者被要求采用更严格的验证通讯协定，并整合连接发现和诊断阶段的跨功能分析平台。采用人工智慧和机器学习进行流程优化进一步凸显了样品处理和分析向数据主导决策的转变。

市场动态也正在重塑竞争格局。学术机构、生物技术公司和大型诊断服务供应商之间的策略联盟正在加速创新萃取方法的开发和商业化。随着公司寻求改进提取通讯协定以处理更多种类的生物流体、适应更小的输入量并解决日益复杂的样本基质，研发方面的投资正在增加。随着无细胞 DNA 技术越来越融入临床实践，市场参与企业致力于不断改进，萃取技术的进步使得诊断结果更快、更准确。

推动市场成长的关键细分洞察

市场区隔为影响产品开发和有针对性的研究的各个方面提供了全面的见解。市场已根据产品类型进行了严格分析，其中包括为自动化处理而设计的高精度仪器、提供用户友好通讯协定的精心设计的套件以及用于增强提取过程的专用试剂。此外，基于无细胞 DNA 类型的细分揭示了循环肿瘤 DNA (ctDNA)、供体来源的无细胞 DNA (dd-cfDNA) 和胎儿 DNA 的专门应用，每种应用都具有独特的优势并满足不同的临床需求。

考虑到处理羊水、血浆、唾液、血清和尿液的复杂性，对样本类型细分的深入了解将进一步丰富我们的理解。每种样品类型都面临独特的挑战，需要客製化的萃取方法来确保最佳的产量和保真度。研究领域的划分同样重要，重点在于癌症生物标记、表观基因、基因组学以及快速发展的液态切片研究领域。这些重点领域将推动创新并为临床应用开闢新的途径。

以应用为中心的细分突出了多种使用案例，例如自体免疫疾病、心血管疾病、感染疾病检测、非侵入性产前检测 (NIPT)、肿瘤学和移植排斥监测。每个应用都需要特定的品质和吞吐量标准，促使製造商整合满足特定临床要求的设计修改。最后，按最终用户进行细分可以深入了解用户需求，包括学术研究机构、生技公司、诊断实验室、医院和製药公司。这些细分有助于对整个市场普遍存在的挑战和机会形成详细的观点，使相关人员能够设计出强大、有针对性和麵向未来的策略性应对措施。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 越来越多地采用液态生物检体进行早期疾病检测
      • 对非侵入性产前检测应用的需求不断增长
      • cfDNA提取自动化和效率的进步
    • 限制因素
      • cfDNA分离萃取试剂套件高成本
    • 机会
      • 扩大cfDNA在移植排斥监测的应用
      • 表观遗传修饰在疾病分析的研究日益增多
    • 任务
      • 跨应用的 cfDNA 萃取通讯协定缺乏标准化
  • 市场区隔分析
    • 产品类型：试剂对维持cfDNA完整性和优化萃取效率的重要性
    • 最终用户：诊断实验室越来越多地采用 cfDNA 萃取技术进行非侵入性检测
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章无细胞DNA分离与萃取市场（依产品类型）

  • 装置
  • 套件
  • 试剂

第七章 游离DNA分离与萃取市场（依游离DNA类型）

  • 循环肿瘤DNA（ctDNA）
  • 供体来源的游离 DNA（dd-cfDNA）
  • 胎儿DNA

8. 无细胞DNA分离与萃取市场（依样本类型）

  • 羊水
  • 电浆
  • 唾液
  • 血清
  • 尿

第九章无细胞DNA分离与萃取市场区隔研究

  • 癌症生物标记
  • 表观基因
  • 基因组学
  • 液态生物检体研究

第 10 章无细胞 DNA 分离与萃取市场：按应用

  • 自体免疫疾病
  • 心血管疾病
  • 感染疾病检测
  • 非侵入性产前检测（NIPT）
  • 肿瘤学
  • 移植排斥监测

第11章 无细胞 DNA 分离与萃取市场（依最终使用者）

  • 学术研究所
  • 生技公司
  • 诊断实验室
  • 医院
  • 製药公司

第 12 章美洲无细胞 DNA 分离与萃取市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区无细胞DNA分离及萃取市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 14 章欧洲、中东和非洲无细胞 DNA 分离与萃取市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbexa Ltd.
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Alpha Laboratories Ltd.
  • AMSBIO LLC
  • BioChain Institute Inc.
  • Covaris, LLC
  • DH Life Sciences, LLC.
  • EntroGen Inc.
  • EpiGentek Group Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • NeoGeneStar LLC
  • Nonacus Limited
  • Norgen Biotek Corporation
  • NVIGEN, Inc.
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation.
  • Streck LLC
  • System Biosciences, LLC
  • Takara Bio Inc. by Takara Holdings Inc
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • Vela Diagnostics by Luye Medical Group Co., Ltd
Product Code: MRR-7C31448F0BA7

The Cell-Free DNA Isolation & Extraction Market was valued at USD 1.09 billion in 2024 and is projected to grow to USD 1.23 billion in 2025, with a CAGR of 13.45%, reaching USD 2.32 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.09 billion
Estimated Year [2025] USD 1.23 billion
Forecast Year [2030] USD 2.32 billion
CAGR (%) 13.45%

In recent years, the field of cell-free DNA isolation and extraction has emerged as a critical contributor to advancements in molecular diagnostics and personalized medicine. Rapid technological evolution coupled with a deeper understanding of genetic biomarkers has significantly redefined the capabilities of both research and clinical applications. As demand surges for high-quality, reproducible results, laboratories and institutions are increasingly investing in innovative methods that streamline the extraction process while maintaining the integrity of precious biological materials.

Scientific communities and decision-makers alike are now recognizing the importance of precise and efficient cell-free DNA extraction techniques. This evolution is underscored by a transition from traditional methods to more sophisticated approaches that emphasize automation, sensitivity, and scalability. Enhanced isolation techniques not only accelerate the detection of genetic aberrations but also facilitate early diagnosis, personalized treatment planning, and the effective monitoring of disease progression.

As competition intensifies among leading biomedical and diagnostic companies, there is a parallel emphasis on developing standardized protocols that are both robust and adaptable across a range of research and clinical environments. The emerging trends in technology integration, regulatory guidance, and evolving market dynamics are dramatically altering the landscape, presenting new opportunities and challenges that warrant expert scrutiny and strategic planning.

Transformative Shifts in the Landscape of Cell-Free DNA Technologies

The landscape of cell-free DNA isolation and extraction has experienced transformative shifts driven by significant technological and scientific innovations. Emerging automation platforms have redefined operational efficiencies, reducing manual intervention while ensuring repeatability and reliability in the extraction process. Advanced instrumentation and improved chemical reagents have paved the way for higher yields and purity levels, which are crucial for downstream applications such as genomic sequencing, liquid biopsies, and non-invasive prenatal testing.

Regulatory changes and evolving quality standards present both challenges and opportunities for industry players. Researchers and industry leaders are now prompted to adopt more rigorous validation protocols and integrate cross-functional analytical platforms that bridge discovery and diagnostic phases. The adoption of artificial intelligence and machine learning for process optimization further underscores a shift towards data-driven decision-making in sample processing and analysis.

Market dynamics are also reshaping the competitive environment. Strategic collaborations between academic institutions, biotech companies, and large-scale diagnostic service providers have accelerated the development and commercialization of innovative extraction methods. Investment in research and development has risen as organizations seek to refine extraction protocols to handle diverse biofluids, cope with lower input volumes, and deal with increasingly complex sample matrices. As cell-free DNA technologies become more integrated into clinical practice, market participants are committed to ongoing improvement, ensuring that advancements in extraction techniques correspond with faster, more accurate diagnostic outcomes.

Key Segmentation Insights Driving Market Growth

The segmentation of the market provides comprehensive insights into various dimensions that influence product development and targeted research. The market is rigorously analyzed based on product type, which includes high-precision instruments engineered for automated processing, carefully designed kits that offer user-friendly protocols, and specialized reagents that enhance the quality of extraction processes. Furthermore, segmentation based on cell-free DNA type reveals specialized applications focused on circulating tumor DNA (ctDNA), donor derived cell-free DNA (dd-cfDNA), and fetal DNA, each offering distinct advantages and meeting varied clinical needs.

Insight into sample type segmentation further enriches our understanding, considering the complexities involved in processing amniotic fluid, plasma, saliva, serum, and urine. Each sample type presents unique challenges that require tailored extraction methodologies, ensuring optimal yield and fidelity. The research area segmentation is equally crucial, with robust emphasis on cancer biomarkers, epigenomics, genomics, and the rapidly evolving field of liquid biopsy research. These focal areas drive innovation and open up new avenues for clinical applications.

Application-focused segmentation highlights the diverse use cases across autoimmune diseases, cardiovascular disorders, infectious disease detection, non-invasive prenatal testing (NIPT), oncology, and transplant rejection monitoring. Each application demands a specific quality and throughput standard, prompting manufacturers to integrate design modifications that cater to distinct clinical requirements. Finally, segmentation by end-user offers insights into user demands, spanning academic and research institutions, biotechnology companies, diagnostic laboratories, hospitals, and pharmaceutical companies. These segmentation categories collectively foster a detailed perspective on the challenges and opportunities prevalent across the market, allowing stakeholders to design strategic responses that are robust, targeted, and future-facing.

Based on Product Type, market is studied across Instruments, Kits, and Reagents.

Based on Cell-Free DNA Type, market is studied across Circulating Tumor DNA (ctDNA), Donor Derived Cell-Free DNA (dd-cfDNA), and Fetal DNA.

Based on Sample Type, market is studied across Amniotic Fluid, Plasma, Saliva, Serum, and Urine.

Based on Research Area, market is studied across Cancer Biomarkers, Epigenomics, Genomics, and Liquid Biopsy Research.

Based on Application, market is studied across Autoimmune Diseases, Cardiovascular Disorders, Infectious Disease Detection, Non-Invasive Prenatal Testing (NIPT), Oncology, and Transplant Rejection Monitoring.

Based on End-User, market is studied across Academic and Research Institutions, Biotechnology Companies, Diagnostic Laboratories, Hospitals, and Pharmaceutical Companies.

Regional Dynamics Shaping the Global Landscape

The global market for cell-free DNA isolation and extraction technologies is not homogenous; it is characterized by significant regional variations and localized trends. In the Americas, robust healthcare infrastructure and extensive investment in genomic research have created a conducive environment for rapid adoption of innovative extraction technologies. Meanwhile, the combined region of Europe, Middle East & Africa demonstrates an integrated approach, characterized by strong regulatory frameworks and emphasis on clinical research, driving consistent demand for state-of-the-art solutions. In the Asia-Pacific region, dynamic economic growth coupled with increasing research funding and an expanding biotech landscape is fostering a vibrant competitive market, pushing boundaries to meet evolving diagnostic needs.

This regional analysis illuminates both established markets and emerging fronts, providing a holistic view of the global trends that shape technological adoption, regulatory compliance, and market expansion. Such insights enable stakeholders to tailor their strategies regionally, ensuring that technology deployment is in tune with local clinical needs and economic circumstances.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Market Leaders and Key Companies in the Space

The competitive dynamics of the cell-free DNA isolation and extraction market are influenced by several key companies that are driving innovation and setting high industry standards. Industry frontrunners such as Abbexa Ltd. and Abnova Corporation contribute significantly through their persistent focus on quality control and technological innovation. Agilent Technologies, Inc. and Alpha Laboratories Ltd. have established themselves as leaders in automation and integrated solutions, whereas AMSBIO LLC and BioChain Institute Inc. continue to push the envelope in reagent development and process standardization.

Covaris, LLC and DH Life Sciences, LLC have demonstrated remarkable agility in adapting to market trends, further bolstering advancements in precision extraction protocols. The robust presence of entities like EntroGen Inc., EpiGentek Group Inc., and F. Hoffmann-La Roche Ltd. underscores the emphasis on research and clinical validation as pivotal drivers of market growth. Additionally, stalwarts such as Illumina, Inc. and Merck KGaA continually influence the market trajectory with innovative sequencing and analysis tools that seamlessly integrate with extraction methodologies. Companies such as NeoGeneStar LLC, Nonacus Limited, and Norgen Biotek Corporation have carved out niche segments by offering specialized solutions tailored to unique sample challenges. NVIGEN, Inc. and Omega Bio-tek, Inc. add to the robust competitive environment by ensuring that their products offer unmatched reliability and integration potential.

Further, firms including PerkinElmer, Inc., Promega Corporation, Streck LLC, System Biosciences, LLC, Takara Bio Inc. by Takara Holdings Inc, Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd. and Vela Diagnostics by Luye Medical Group Co., Ltd. are leading efforts in diversifying product portfolios and expanding into new therapeutic and diagnostic modalities. These companies collectively fuel the overall innovation curve, driving not only product improvements but also the evolution of standards and best practices in cell-free DNA isolation and extraction technologies.

The report delves into recent significant developments in the Cell-Free DNA Isolation & Extraction Market, highlighting leading vendors and their innovative profiles. These include Abbexa Ltd., Abnova Corporation, Agilent Technologies, Inc., Alpha Laboratories Ltd., AMSBIO LLC, BioChain Institute Inc., Covaris, LLC, DH Life Sciences, LLC., EntroGen Inc., EpiGentek Group Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, NeoGeneStar LLC, Nonacus Limited, Norgen Biotek Corporation, NVIGEN, Inc., Omega Bio-tek, Inc., PerkinElmer, Inc., Promega Corporation., Streck LLC, System Biosciences, LLC, Takara Bio Inc. by Takara Holdings Inc, Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and Vela Diagnostics by Luye Medical Group Co., Ltd. Actionable Strategies for Industry Leaders

Industry leaders are encouraged to adopt a forward-thinking approach in addressing the rapidly changing dynamics of cell-free DNA isolation and extraction. A key recommendation is to increase investment in state-of-the-art research and development programs to refine extraction protocols and enhance automation. By prioritizing innovation, companies can harness the benefits of improved sensitivity, faster turnaround times, and enhanced compatibility with emerging diagnostic techniques.

Another strategic consideration involves forming partnerships and strategic alliances with academic research institutions and biotechnology companies. Such collaborations facilitate knowledge-sharing, accelerate the adoption of novel technologies, and create synergies that strengthen competitive positions in a rapidly evolving market. Leaders should also focus on expanding their global footprint, particularly by entering and establishing a presence in high-growth regions characterized by dynamic research activities and robust healthcare infrastructure.

Attention must be given to the development of bespoke solutions that target specific market segments. Tailoring products to meet the nuanced requirements of various applications-from oncology to prenatal testing-can significantly enhance customer satisfaction and build long-term brand loyalty. Additionally, aligning product development with evolving regulatory standards will ensure that new innovations are both commercially viable and compliant with international safety and quality norms.

Lastly, investing in training and continuous education programs for laboratory personnel and end-users can further optimize the extraction process, reduce error margins, and improve overall operational efficiency. By championing a culture of continuous improvement and proactive strategy adaptation, industry leaders can secure a competitive edge and drive market growth sustainably.

Conclusion: The Future of Cell-Free DNA Technologies

The rapid advancements in cell-free DNA isolation and extraction underscore a pivotal era in genetic research and clinical diagnostics. Through the integration of innovative technologies, the industry is achieving unprecedented levels of efficiency and precision, setting the stage for breakthroughs in personalized medicine and early disease detection. The evolving market dynamics reveal robust opportunities for stakeholders who embrace technological innovation, adapt to regulatory changes, and strategically navigate emerging regional trends.

This comprehensive analysis emphasizes that a deep understanding of market segmentation, regional distinctions, and key competitive players is essential for crafting successful business strategies. With a focus on quality, collaboration, and continual innovation, the industry is poised to redefine standards in molecular extraction and propel the future of diagnostic methodologies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of liquid biopsy for early disease detection
      • 5.1.1.2. Rising demand for non-invasive prenatal testing applications
      • 5.1.1.3. Advancements in automation and efficiency of cfDNA extraction
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cfDNA isolation and extraction kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding applications of cfDNA in transplant rejection monitoring
      • 5.1.3.2. Growing research on epigenetic modifications for disease analysis
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization in cfDNA extraction protocols across applications
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Significance of reagents in preserving cfDNA integrity and optimizing extraction efficiency
    • 5.2.2. End-User: Growing adoption of cfDNA extraction in diagnostic laboratories for non-invasive testing
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell-Free DNA Isolation & Extraction Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits
  • 6.4. Reagents

7. Cell-Free DNA Isolation & Extraction Market, by Cell-Free DNA Type

  • 7.1. Introduction
  • 7.2. Circulating Tumor DNA (ctDNA)
  • 7.3. Donor Derived Cell-Free DNA (dd-cfDNA)
  • 7.4. Fetal DNA

8. Cell-Free DNA Isolation & Extraction Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Amniotic Fluid
  • 8.3. Plasma
  • 8.4. Saliva
  • 8.5. Serum
  • 8.6. Urine

9. Cell-Free DNA Isolation & Extraction Market, by Research Area

  • 9.1. Introduction
  • 9.2. Cancer Biomarkers
  • 9.3. Epigenomics
  • 9.4. Genomics
  • 9.5. Liquid Biopsy Research

10. Cell-Free DNA Isolation & Extraction Market, by Application

  • 10.1. Introduction
  • 10.2. Autoimmune Diseases
  • 10.3. Cardiovascular Disorders
  • 10.4. Infectious Disease Detection
  • 10.5. Non-Invasive Prenatal Testing (NIPT)
  • 10.6. Oncology
  • 10.7. Transplant Rejection Monitoring

11. Cell-Free DNA Isolation & Extraction Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic and Research Institutions
  • 11.3. Biotechnology Companies
  • 11.4. Diagnostic Laboratories
  • 11.5. Hospitals
  • 11.6. Pharmaceutical Companies

12. Americas Cell-Free DNA Isolation & Extraction Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cell-Free DNA Isolation & Extraction Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cell-Free DNA Isolation & Extraction Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. CD Bioparticles unveils next-gen exosome isolation kits for enhanced liquid biopsy and personalized medicine
    • 15.3.2. Takara Bio USA Holdings acquires Curio Bioscience to integrate spatial genomics innovations with single-cell omics for enhanced insights in cancer
    • 15.3.3. QIAGEN expands automated liquid biopsy portfolio to enhance cell-free DNA isolation and extraction for improved diagnostic accuracy in oncology
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbexa Ltd.
  • 2. Abnova Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Alpha Laboratories Ltd.
  • 5. AMSBIO LLC
  • 6. BioChain Institute Inc.
  • 7. Covaris, LLC
  • 8. DH Life Sciences, LLC.
  • 9. EntroGen Inc.
  • 10. EpiGentek Group Inc.
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Illumina, Inc.
  • 13. Merck KGaA
  • 14. NeoGeneStar LLC
  • 15. Nonacus Limited
  • 16. Norgen Biotek Corporation
  • 17. NVIGEN, Inc.
  • 18. Omega Bio-tek, Inc.
  • 19. PerkinElmer, Inc.
  • 20. Promega Corporation.
  • 21. Streck LLC
  • 22. System Biosciences, LLC
  • 23. Takara Bio Inc. by Takara Holdings Inc
  • 24. Thermo Fisher Scientific Inc.
  • 25. TransGen Biotech Co., Ltd.
  • 26. Vela Diagnostics by Luye Medical Group Co., Ltd

LIST OF FIGURES

  • FIGURE 1. CELL-FREE DNA ISOLATION & EXTRACTION MARKET MULTI-CURRENCY
  • FIGURE 2. CELL-FREE DNA ISOLATION & EXTRACTION MARKET MULTI-LANGUAGE
  • FIGURE 3. CELL-FREE DNA ISOLATION & EXTRACTION MARKET RESEARCH PROCESS
  • FIGURE 4. CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. CELL-FREE DNA ISOLATION & EXTRACTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. CELL-FREE DNA ISOLATION & EXTRACTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CELL-FREE DNA ISOLATION & EXTRACTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL-FREE DNA ISOLATION & EXTRACTION MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CIRCULATING TUMOR DNA (CTDNA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY DONOR DERIVED CELL-FREE DNA (DD-CFDNA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY FETAL DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY AMNIOTIC FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY LIQUID BIOPSY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY INFECTIOUS DISEASE DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY TRANSPLANT REJECTION MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY CELL-FREE DNA TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM CELL-FREE DNA ISOLATION & EXTRACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. CELL-FREE DNA ISOLATION & EXTRACTION MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 290. CELL-FREE DNA ISOLATION & EXTRACTION MARKET, FPNV POSITIONING MATRIX, 2024